Related Experiment Video
Updated: Jul 21, 2026
07:57
Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
Evolving pathogens in vulvovaginal candidiasis: implications for patient care
B J Horowitz1, D Giaquinta, S Ito
1Department of Obstetrics and Gynecology, University of Connecticut, Farmington.
Journal of Clinical Pharmacology
|March 1, 1992
Summary
A rise in non-albicans yeast vaginitis, particularly Candida tropicalis and Candida glabrata, is observed. Shorter antifungal therapies may promote these resistant species, necessitating broader-spectrum treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Yeast vaginitis is commonly caused by Candida albicans.
- An increasing incidence of infections by non-albicans Candida species has been noted over the past two decades.
- Candida tropicalis and Candida glabrata are the most significant non-albicans species implicated.
Purpose of the Study:
- To highlight the emerging trend of non-albicans yeast vaginitis.
- To discuss the implications of this trend on current treatment strategies.
- To explore potential reasons for the increased prevalence of non-albicans species.
Main Methods:
- Literature review and analysis of epidemiological trends in yeast vaginitis.
- Examination of the efficacy of current antifungal therapies against non-albicans species.
- Hypothesis generation regarding the impact of short-course antifungal regimens.
Main Results:
- Non-albicans Candida species, specifically C. tropicalis and C. glabrata, are increasingly causing vaginal infections.
- Standard antifungal treatments effective against Candida albicans show reduced efficacy against these non-albicans species.
- Shortened (1-3 day) antifungal therapy regimens may inadvertently select for non-albicans species by suppressing C. albicans and disrupting vaginal flora.
Conclusions:
- The changing landscape of yeast vaginitis necessitates a re-evaluation of diagnostic and therapeutic approaches.
- Accurate identification of yeast species is crucial for effective treatment.
- Broad-spectrum antifungal agents capable of eradicating both C. albicans and prevalent non-albicans species are needed.
Related Concept Videos
01:26Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
01:25Urinary Tract Infection II: Pathophysiology
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
01:28Microbiota of the Urogenital Tract
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.